This remarkably agrees with the impact of the regular consumption of the non-selective A2AR antagonist, caffeine, on age and AD-related memory impairment (Cunha and Agostinho, 2010), PD (Ascherio et al., 2003), and major depression (Lucas et al., 2011). This evidence concerns the gene ADORA2A and Alzheimer disease.